When did "we believe we reached physicians" become an acceptable standard for a billion-dollar industry? Somewhere along the way, pharma marketing made peace with probabilistic targeting, inferred identities, and impression counts that looked impressive but proved little. The industry didn't lower its clinical standards. It just never applied them to its media buying.
That disconnect is no longer sustainable. And it's not a media buying problem. It's a structural one.
The Illusion of
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Bristol Myers Squibb Partners with Chai Discovery for AI Antibody Design
What You Should Know
Chai Discovery announced a strategic biopharmaceutical collaboration with Bristol Myers Squibb (BMS) to advance the discovery and engineering of therapeutic antibodies using artificial intelligence.Bristol Myers Squibb will integrate Chai’s proprietary molecular folding and de novo design models across its drug discovery portfolio to power an AI-driven, continuously learning discovery system.Chai Discovery’s platform acts as a computer-aided design (CAD) suite for
Read More
DCAI and Corti Launch Sovereign AI Control Layer on Gefion Supercomputer
What You Should Know
The Danish Center for AI Innovation (DCAI) and clinical AI lab Corti have launched Corti Models, a governed, model-agnostic infrastructure layer providing European enterprises with sovereign control over AI deployments, data security, and compliance.The platform provides an OpenAI-compatible API supporting sovereign cloud and on-premises environments, allowing organizations to route workloads to leading foundation models without rewriting existing SDK integrations or
Read More
Aily Labs Partners with Google Cloud to Scale AI Decision Intelligence for Pharma and Biotech
What You Should Know
Aily Labs, developer of an AI-native Decision Intelligence platform, announced a strategic partnership with Google Cloud to launch its platform on the Google Cloud Marketplace.The collaboration enables global life sciences, pharmaceutical, and biotech enterprises to procure and deploy Aily’s AI agents directly through existing Google Cloud contracts, counting toward committed cloud spend without additional vendor or compliance reviews.Aily’s decision-ready agents
Read More
Craif Secures $33M to Bring AI-Powered Urine Oncology Diagnostics to the U.S.
What You Should Know
Craif Inc., a bio-AI company developing a non-invasive urine analysis platform for early cancer detection, closed an approximately $33M Series D round (¥5.28 billion), bringing its total capital raised to roughly $88M (¥14.2 billion).The financing was co-led by Granite-Integral (a joint venture between Granite Asia and Integral Corporation) and TAUNS Laboratories, Inc. (one of Japan’s largest rapid diagnostic test manufacturers), with participation from U.S.-based
Read More
Your GLP-1 Prescription Is Table Stakes. Now What?
Virtual clinics are very good at getting GLP-1s into patients' hands fast. That chapter is behind us, and the margins are compressing to prove it.
Leaders like Ro, hims & hers, Calibrate and Found have started building more holistic health solutions, layering in coaching, CGMs, and behavioral support. That is a decent first step. But breadth without depth isn't a moat; it's a feature set. And it’s only a matter of time before feature sets get copied.
Moreover “holistic” by itself begs
Read More
Viome Life Sciences Acquires Circulate Health to Launch Viome Professional Clinical Group
What You Should Know
Viome Life Sciences announced the acquisition of Circulate Health, a developer of outpatient therapeutic plasma exchange (TPE) protocols targeting healthspan extension and chronic disease management.The transaction bridges Viome’s molecular diagnostic, microbiome, and precision nutrition platform with Circulate’s physician-guided outpatient TPE protocols and nationwide network of partner clinics staffed by specialized nurses.Circulate Health Co-Founder and CEO Dr. Brad
Read More
From “Maybe” to Baltic Gods: The Stories Behind Virus Names
Hundreds of new RNA viruses are discovered every year, but every discovery brings an unexpected challenge: what should the new virus be called? While some names describe where a virus was found or which species it infects, others draw inspiration from mythology, language, biology and even heavy metal music.
Among the viruses officially recorded in international genetic sequence databases are Galbūt ("Maybe"), Ūsinis, Barstukas, Pikulas and Patulas, all named by Lithuanian virologist Dr Gytis
Read More
H1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development
What You Should Know
Healthcare data and AI platform H1 announced a strategic partnership with global pharmaceutical leader Novo Nordisk to modernize clinical trial development.Under the agreement, H1 will acquire rights to further advance StudyHub, Novo Nordisk's proprietary digital and AI-enabled platform for clinical trial execution.The collaboration combines H1's global Doctor Graph and AI-ready datasets with Novo Nordisk’s clinical trial operations to optimize protocol design, site
Read More
Inocras Closes $31M for Whole-Genome Bioinformatics Platform
What You Should Know
San Diego-based bioinformatics company Inocras Inc. closed an oversubscribed $31M Series B-3 financing round, bringing its total capital raised to approximately $100M.The funding round was supported by strategic investors NDS Corporation and Aimed Bio Inc., alongside new investors IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment & Securities, and Shinhan Securities.Proceeds will fund the U.S. expansion of
Read More
